AI will revolutionize drug discovery — but only if experts are involved

In the clinical setting, AI works with known parameters, typically running through a classification process based on experiences of what works and what doesn’t for different types of patients. The potential of AI here is significant, and the early successes are truly exciting.

The opportunity is equally compelling in drug discovery, particularly in areas of high unmet need such as rare and hard-to-treat cancers and neurodegenerative conditions.